Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
14.51
+0.01 (0.07%)
At close: Sep 18, 2026, 4:00 PM EDT
14.70
+0.19 (1.31%)
Pre-market: Sep 21, 2026, 9:03 AM EDT
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $1.43 billion as of September 18, 2026. Its market cap has decreased by -48.45% in one year.
Market Cap
1.43B
Enterprise Value
2.19B
1-Year Change
-48.45%
Ranking
Category
Stock Price
$14.51
ChartMarket Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $1.43B, an increase of 19.96%. That is a compound annual growth rate of 1.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.43B | -35.53% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.50B |
| Latigo Biotherapeutics | 1.50B |
| ArriVent BioPharma | 1.42B |
| Alpha Tau Medical | 1.41B |
| Avalyn Pharma | 1.40B |
| Damora Therapeutics | 1.39B |
| Ascentage Pharma Group International | 1.39B |
| First Tracks Biotherapeutics | 1.38B |